TENOSYNOVIAL GIANT CELL TUMOR
Clinical trials for TENOSYNOVIAL GIANT CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR trials appear
Sign up with your email to follow new studies for TENOSYNOVIAL GIANT CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare joint tumor: drug trial targets tumor control
Disease control Recruiting nowThis study tests a drug called pimicotinib in 20 Japanese adults with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous tumor that grows around joints and can cause pain and stiffness. The goal is to see if the drug can shrink the tumor and improve symptoms. Participant…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New pill for tough tumors enters first human tests
Disease control Recruiting nowThis early-stage study tests an experimental pill called ABSK021 in people with advanced solid tumors (including a rare joint tumor called TGCT) who have run out of standard options. The main goal is to check safety and find the right dose, while also seeing if the drug can shrin…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Glow-in-the-dark dye helps surgeons spot hidden tumor cells during surgery
Diagnosis Recruiting nowThis study tests whether a dye called indocyanine green (ICG) can help surgeons see tenosynovial giant cell tumors (TGCT) during surgery. About 40 people with TGCT will get an ICG injection before their operation, and surgeons will use a special camera to spot glowing tumor tissu…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Diagnosis
Last updated May 26, 2026 08:04 UTC
-
New study tracks Real-World use of vimseltinib for rare tumor
Knowledge-focused Recruiting nowThis study observes 100 people with tenosynovial giant cell tumor (TGCT) who are taking vimseltinib as part of their normal care. Researchers will collect data on how long patients stay on the drug and how it affects their quality of life. No extra treatments or changes to care a…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Knowledge-focused
Last updated May 26, 2026 07:26 UTC
-
Liver risk under the microscope: TURALIO long-term study recruits 30 patients
Knowledge-focused Recruiting nowThis study follows up to 30 adults with tenosynovial giant cell tumor (TGCT) who had liver test abnormalities while taking TURALIO (pexidartinib). The goal is to track long-term risk of liver failure and understand the mechanism of liver injury through optional biopsies. Particip…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC